May 27, 2019, SEOUL, South Korea – Today marks the official kick-off meeting of the CAPTURA (‘Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia’) project, an international consortium led by IVI. This 2-day workshop brings together partners including the Public Health Surveillance Group (PHSG), the Brigham and Women’s Hospital in the U.S., the University of Oxford’s Big Data Institute (BDI) and The Fleming Fund in the U.K. at IVI’s headquarters in Seoul.
AMR is spreading at alarmingly high rates, affecting the health of populations worldwide and becoming one the most pressing threats to human existence. If current trends persist, there will be 10 million deaths annually by 2050, and a yearly cost of 100 trillion dollars*.
IVI’s work with CAPTURA is based on the belief that stronger data will inform better policy and that vaccines have an important role to play combatting AMR.